Establishment profile
Alexion Pharmaceuticals, Inc.
350 Knotter Drive, Cheshire, CT, 06410
Operated by Alexion Pharmaceuticals, Inc · 1 of 2 establishments
32541 — Pharmaceutical and Medicine Manufacturing
Summary
Alexion Pharmaceuticals, Inc. has no OSHA inspection history on file. Federal records covering wage, environmental, labor relations, and other agencies are noted below where present.
The most recent federal enforcement activity was recorded 21 years ago.
Federal records were found in 1 of 15 sources. Sources without matching records returned empty for this establishment.
Agency coverage
Alexion Pharmaceuticals, Inc. appears in WHD wage enforcement record only. No matching records were found in OSHA workplace safety, MSHA mine safety, EPA environmental compliance, NLRB labor relations, OFLC visa and labor certification (historical), FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, CPSC product recalls, or NHTSA vehicle recalls. Single-agency enforcement records typically indicate either a discrete incident-based inspection or a low-risk operational profile.
OSHA workplace safety
No OSHA inspections, citations, or accidents on file for Alexion Pharmaceuticals, Inc.. Verify directly with Occupational Safety and Health Administration →
Safety self-report (OSHA 300A)
Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.
Reported for 506 average annual employees at this establishment.
Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.
Industry benchmark
BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.
OSHA severe injury reports
No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for Alexion Pharmaceuticals, Inc.. Verify directly with Occupational Safety and Health Administration →
Activity timeline
No federal enforcement activity has been recorded against this establishment in 21+ years. Most recent activity: 21 years ago. Data on this page is refreshed weekly.
Wage & Hour Division (WHD)
Department of Labor Wage & Hour Division — minimum-wage, overtime, child-labor, FMLA, and prevailing-wage enforcement.
Wage and hour cases
Closed DOL Wage & Hour Division cases (FLSA, FMLA, H-2B, MSPA, and related statutes). Backwages reflect amounts the agency assessed; civil penalty (CMP) is a separate fine levied on top, where the statute provides for one (FLSA / H-1B / H-2A / MSPA / FMLA / EPPA / FLSA Child Labor; other acts have no CMP column in DOL’s data). The Statutes column lists which laws each case cited. 1 case · $0 in backwages
| Case period | Industry | Statutes | Violations | Workers | Backwages | Civil penalty |
|---|---|---|---|---|---|---|
| Sep 2002 – Sep 2004 | Pharmaceutical and Medicine Manufacturing | — | — | 0 | — | — |
Source: DOL WHD enforcement database. Cases shown reflect those the agency has closed and made public. A violation count is the agency’s tally of cited violations (one violation can affect many workers); the workers column counts distinct employees the agency found to be affected.
Mine safety (MSHA)
No MSHA mine safety violations on file for Alexion Pharmaceuticals, Inc.. Verify directly with Mine Safety and Health Administration →
Labor relations (NLRB)
No NLRB unfair labor practice charges or union representation cases on file for Alexion Pharmaceuticals, Inc.. Verify directly with National Labor Relations Board →
Visa & labor certification (OFLC) — historical
No H-1B, H-2A, or H-2B labor condition applications on file (historical data only — DOL ended OFLC publication) for Alexion Pharmaceuticals, Inc.. Verify directly with Office of Foreign Labor Certification →
Environmental compliance (EPA)
No EPA inspections or formal enforcement actions on file for Alexion Pharmaceuticals, Inc.. Verify directly with Environmental Protection Agency →
EPA-registered facilities
Every EPA ECHO facility associated with this employer, sorted most-significant first. Each row links to EPA’s Detailed Facility Report for the source-of-truth record. Permits column lists active programs (Air = Clean Air Act, Water = Clean Water Act, RCRA = hazardous waste, TRI = Toxics Release Inventory reporting). 1 facility.
| Facility | Permits | Status | Inspections | Formal actions | Penalties | Last inspected | ECHO |
|---|---|---|---|---|---|---|---|
ALEXION PHARMACEUTICALS INC. 352 KNOTTER DR · CHESHIRE, CT, 06410 | RCRA | No Violation Identified | 0 | 0 | — | — | View → |
Source: EPA ECHO (Enforcement and Compliance History Online). Compliance status follows EPA’s own labels (“Sig Violation” = significant noncompliance; QNCR = quarters of noncompliance over the recent reporting window). Inactive facilities (struck through) retain historical enforcement records even after operations ceased.
Federal criminal prosecution record
No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for Alexion Pharmaceuticals, Inc.. Verify directly with UVA Corporate Prosecution Registry →
Federal contracts
This location
- Department of Veterans AffairsPHARMACEUTICALScontract · Last action 2015-01-22$355,687
- Department of Veterans AffairsDIRECT PATIENT CARE - EMERGENCY CHEMO DRUGcontract · Last action 2013-11-21$300,289
- Department of Veterans AffairsSOLIRIS MEDICATION POP: 10/1/2016 TO 9/30/2017contract · Last action 2016-10-01$291,431
- Department of Veterans AffairsPHARAMACEUTICAL DRUGS: BLOOD DERIVATIVES: SOLIRIS, 300MGcontract · Last action 2014-11-14$290,579
- Department of Veterans AffairsPHARMACY MEDICATIONScontract · Last action 2017-02-21$285,412
- Department of Veterans AffairsPHARMACEUTICAL DRUGS (PT. MEDICATION) - SOLIRIS 300MG, VIALScontract · Last action 2012-01-19$275,313
- Department of Veterans AffairsSOLIRIScontract · Last action 2015-02-03$258,169
- Department of Veterans AffairsVIALS ALEXION 48 QTYcontract · Last action 2014-12-04$167,130
- Department of Veterans AffairsSOLIRIScontract · Last action 2015-02-18$158,925
- Department of Veterans AffairsECULIZUMAB 300MG/VIALcontract · Last action 2015-01-23$140,064
- Department of Veterans AffairsCHEMOTHERAPY PHARMACEUTICALScontract · Last action 2013-04-18$138,935
- Department of Veterans AffairsPHARMACEUTICAL PURCHASE OF SOLARIScontract · Last action 2014-02-13$122,922
- Department of Veterans AffairsPHARMACEUTICAL DRUGS: SOLIRIS- STANDING ORDER FOR SPECIFIC PATIENT.contract · Last action 2013-01-30$117,884
- Department of Veterans AffairsSOLIRIScontract · Last action 2017-09-13$111,168
- Department of Veterans AffairsPHARMACY PRODUCTScontract · Last action 2009-05-05$102,948
- Department of Veterans AffairsIGF::CL::IGF SOLIRIS STANDING PHARMACY ORDER FOR CHEMOcontract · Last action 2014-07-18$101,495
- Department of Veterans AffairsPHARMACEUTICAL PURCHASE OF SOLARIScontract · Last action 2013-08-29$101,044
- Department of Veterans AffairsBLOOD DERIVATIVES SOLIRIScontract · Last action 2008-03-13$91,452
- Department of Veterans AffairsSOLIRIS 300 MG VIALcontract · Last action 2015-11-19$89,993
- Department of Veterans AffairsSOLIRIS (ECULIZUMAB) CHEMO DRUGcontract · Last action 2013-08-08$88,413
- Department of Veterans AffairsSOLIRIS DRUGcontract · Last action 2012-12-17$85,571
- Department of Veterans AffairsSOLIRIScontract · Last action 2012-09-18$85,570
- Department of Veterans AffairsSOLIRIS 300MG VIAL (THIS ORDER BELONGS TO EDNA SANCHEZ.)contract · Last action 2010-04-26$80,071
- Department of Veterans AffairsPHARMACY PRODUCTScontract · Last action 2009-01-16$80,071
- Department of Veterans AffairsSTANDING ORDER SOLIRIS, 21 VIALS, 3000MGcontract · Last action 2008-10-23$80,071
- Department of Veterans AffairsBLOOD DERIVATIVES SOLIRIScontract · Last action 2008-07-15$80,071
- Department of Veterans AffairsSOLARIS 300MG VIALcontract · Last action 2009-10-06$80,070
- Department of Veterans AffairsSOLIRIS CHEMO DRUGcontract · Last action 2014-01-08$77,137
- Department of JusticeIGF::CL::IGF THIS ORDER CAN ONLY BE PLACED WITH THE ABOVE VENDOR. FSS#V797D-30015-SOLIRIS (ECUILZUMAB) 10MG/ML INJECTIONS (2 TREATMENTS) NO REFUNDS AND OR RETURNS LARGE BUSINESScontract · Last action 2014-11-07$68,953
- Department of JusticeIGF::CT::IGF THIS ORDER CAN ONLY BE PLACED WITH THE ABOVE VENDOR. FSS#V797D-30015-SOLIRIS (ECUILZUMAB) 10MG/ML INJECTIONS (2 TREATMENTS) NO REFUNDS AND OR RETURNS LARGE BUSINESScontract · Last action 2014-10-01$68,953
- Department of Veterans AffairsSMALL PURCHASE DATAcontract · Last action 2009-07-07$68,631
- Department of Veterans AffairsSOLIRIS (ECULIZUMAB) 300MGcontract · Last action 2009-07-07$68,631
- Department of Veterans AffairsPHARMACY - SOLIRIScontract · Last action 2014-07-16$68,566
- Department of Veterans Affairs18 VIALS OF SOLIRIS 300MG FOR VA MILWAUKEEcontract · Last action 2010-09-15$67,502
- Department of Veterans AffairsECULIZUMAB 10MG/ML SOLN INJ(SOLIRIS)contract · Last action 2007-12-11$64,658
- Department of Veterans AffairsECULAZUMAB (SOLIRIS) INJ 10MG/MLcontract · Last action 2018-01-30$58,836
- Department of Veterans AffairsEXPRESS REPORT - IFCAP TO FPDS-NG REJECTS A01346 614-10-3-031-0287 A01483 614-10-3-031-0339 A01530 614-10-3-031-0359 A01616 614-10-3-031-0402contract · Last action 2010-03-01$56,251
- Department of Veterans AffairsPHARMACEUTICAL ECULAZUMABcontract · Last action 2017-12-07$55,584
- Department of Veterans Affairs12 VIALS OF SOLIRIS FOR PATIENT TREATMENTcontract · Last action 2017-08-04$55,584
- Department of Veterans AffairsECULIZUMAB VIALScontract · Last action 2017-06-27$55,584
- Department of Veterans AffairsECULAZUMAB (SOLIRIS) INJ 100MG/MLcontract · Last action 2017-05-15$55,584
- Department of Veterans AffairsSOLIRIS INJ 10MG/MLcontract · Last action 2017-04-10$55,584
- Department of Veterans AffairsECULAZUMAB (SOLIRIS) INJ. 10MG/MLcontract · Last action 2017-02-25$55,584
- Department of Veterans AffairsECULAZUMAB MEDICATIONcontract · Last action 2017-01-11$53,760
- Department of Veterans AffairsSOLIRIScontract · Last action 2016-10-07$53,760
- Department of Veterans AffairsSOLIRIS INJ 10MG/ML MEDICATIONcontract · Last action 2016-08-29$53,760
- Department of Veterans AffairsSOLIRIS INJECTION 20MG/ML FOR TREATMENT OF PATIENTS AT THE DETROIT VAMCcontract · Last action 2016-04-22$53,760
- Department of Veterans AffairsPHARMACY - SOLIRIScontract · Last action 2014-06-06$51,425
- Department of Veterans AffairsSOLIRIS 10MG/MLcontract · Last action 2014-03-12$51,425
- Department of Veterans AffairsSOLORIS (ECULIZUMAB)300MG/VIALcontract · Last action 2013-05-26$50,522
Federal contract dollars to this establishment. Primary NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING. Last action: 2018-03-22. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.
In the news
Part of a larger organization
Alexion Pharmaceuticals, Inc. is one of 2 establishments rolled up under the parent organization Alexion Pharmaceuticals, Inc.
Federal enforcement records on this page represent activity at this specific establishment only. The full enforcement footprint of Alexion Pharmaceuticals, Inc across all 2 of its tracked locations is viewable on the parent profile.
Other locations under this parent
Other establishments operated by Alexion Pharmaceuticals, Inc, ordered by federal enforcement volume:
- ALEXION PHARMACEUTICALS, INC.SMITHFIELD, RI — 1 federal enforcement record
Related searches
- All Alexion Pharmaceuticals, Inc locationsParent rollup
- Pharmaceutical and Medicine ManufacturingAll employers in this industry
- Employers in CTState-wide enforcement data
- Pharmaceutical and Medicine in CTIndustry × state cross-filter
About this data
This profile aggregates federal enforcement records on Alexion Pharmaceuticals, Inc. from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.
Establishments are matched across agencies using normalized employer name, state, and ZIP code. This establishment resolves to the parent rollup Alexion Pharmaceuticals, Inc, which operates 2 establishments in our dataset.
OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.
Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.
Contact sales →Frequently asked
- What is Alexion Pharmaceuticals, Inc.'s OSHA violation history?
- Alexion Pharmaceuticals, Inc. has no OSHA inspections on record.
- How does Alexion Pharmaceuticals, Inc.'s safety record compare to its industry?
- Alexion Pharmaceuticals, Inc. operates in the pharmaceutical and medicine manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. Alexion Pharmaceuticals, Inc.'s self-reported DART rate is 0.35 compared to an industry average of 0.9.